Čájehuvvojit 1 - 8 oktiibuot 8 bohtosis ohcui Serena Macrini (16006032)', ohcanáigi: 0,01s Aiddostahte ozu
  1. 1
    Supplementary Figure S6 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

    Supplementary Figure S6 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer Dahkki Alessio Cortellini (11023993)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Supplementary Figure S8 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

    Supplementary Figure S8 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer Dahkki Alessio Cortellini (11023993)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Supplementary Figure S5 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

    Supplementary Figure S5 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer Dahkki Alessio Cortellini (11023993)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Supplementary Figure S7 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

    Supplementary Figure S7 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer Dahkki Alessio Cortellini (11023993)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Supplementary Figure S4 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

    Supplementary Figure S4 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer Dahkki Alessio Cortellini (11023993)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Supplementary Figure S2 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

    Supplementary Figure S2 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer Dahkki Alessio Cortellini (11023993)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Supplementary Figure S3 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

    Supplementary Figure S3 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer Dahkki Alessio Cortellini (11023993)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Supplementary Figure S1 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

    Supplementary Figure S1 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer Dahkki Alessio Cortellini (11023993)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: